Skye Bioscience, Inc.

OTC:SKYE

1.55 (USD) • At close November 27, 2023
Bedrijfsnaam Skye Bioscience, Inc.
Symbool SKYE
Munteenheid USD
Prijs 1.74
Beurswaarde 1,690,497,028
Dividendpercentage 0%
52-weken bereik 0.007 - 10
Industrie Biotechnology
Sector Healthcare
CEO Mr. Punit S. Dhillon B.A., BA
Website https://skyebioscience.com

An error occurred while fetching data.

Over Skye Bioscience, Inc.

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to

Vergelijkbare Aandelen

Chalice Brands Ltd. logo

Chalice Brands Ltd.

CHALF

0 USD

BioCorRx Inc. logo

BioCorRx Inc.

BICX

1.2 USD

Healthy Extracts Inc. logo

Healthy Extracts Inc.

HYEX

0.053 USD

WEED, Inc. logo

WEED, Inc.

BUDZ

0.087 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)